Endologix receives FDA Breakthrough Device Designation for ChEVAS system for sealing endovascular aneurysm
Endologix, a California-based, global medical device company focussed on the treatment of vascular disease, says the company’s ChEVAS (Chimney EndoVascular Aneurysm Sealing) System has been granted a Breakthrough Device Designation from the US FDA. The ChEVAS System is an investigational endovascular abdominal aortic aneurysm (AAA) sealing therapy designed to combine the Nellix 3.5 endograft with […]